Vega Investment Solutions Acquires Shares of 10,284 The Cooper Companies, Inc. $COO

Vega Investment Solutions acquired a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 10,284 shares of the medical device company’s stock, valued at approximately $737,000.

Other large investors have also modified their holdings of the company. Avalon Trust Co purchased a new stake in shares of Cooper Companies during the 2nd quarter valued at about $25,000. Root Financial Partners LLC boosted its holdings in Cooper Companies by 104.5% in the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after acquiring an additional 162 shares during the period. SJS Investment Consulting Inc. boosted its holdings in Cooper Companies by 107.5% in the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock worth $26,000 after acquiring an additional 187 shares during the period. Elevation Wealth Partners LLC grew its position in Cooper Companies by 1,136.4% in the second quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company’s stock valued at $29,000 after acquiring an additional 375 shares in the last quarter. Finally, J.Safra Asset Management Corp purchased a new stake in shares of Cooper Companies during the second quarter valued at approximately $32,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently commented on COO. Needham & Company LLC reduced their target price on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating on the stock in a research report on Friday, June 5th. Robert W. Baird lowered their price target on shares of Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a report on Friday, June 5th. UBS Group initiated coverage on shares of Cooper Companies in a research note on Tuesday, July 28th. They set a “neutral” rating and a $75.00 price target on the stock. Wells Fargo & Company reiterated a “sell” rating and issued a $66.00 price objective (down from $82.00) on shares of Cooper Companies in a report on Friday, June 5th. Finally, KeyCorp reissued a “sector weight” rating on shares of Cooper Companies in a research report on Friday, June 5th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $81.64.

Cooper Companies Stock Performance

Shares of COO opened at $75.80 on Tuesday. The firm has a market cap of $14.78 billion, a price-to-earnings ratio of 64.24, a PEG ratio of 1.99 and a beta of 0.83. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23. The business’s 50 day moving average is $72.09 and its two-hundred day moving average is $71.07. The Cooper Companies, Inc. has a 52-week low of $58.89 and a 52-week high of $89.83.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. The business had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The business’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same quarter last year, the company earned $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Analysts forecast that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.